N/A
N=47
The Momba Mobile Application-based Community
Mental Health Wellness 1
Bottom Line
View on ClinicalTrials.gov: NCT01816945 ↗Enrolled (actual)
47
Serious AEs
0.0%
Results posted
May 2021
Primary outcome: Primary: Phone Retention — 9; 15; 14; 9 Participants — p=0.15
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- MOMBA web-based application (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Yale University
- Primary completion
- Jun 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Phone Retention |
9; 15; 14; 9 | 0.15 |
| PRIMARY Test the Proper Operating and Functioning of the MOMBA Application |
23; 24; 0; 0 | — |
| SECONDARY Acceptability and Performance of Structured Questionnaires |
20; 19; 3; 5 | — |
Summary
The investigators' mobile application-based community, termed Momba, will provide a bi-directional flow of information on maternal and infant mental health to traditionally underrepresented groups of mothers and their infants. The overall goal of this mobile application-based community of low-income postpartum women and infants is to increase the social support, social networks, and social capital of low-income mothers; thereby, leading to a positive change in the health behaviors, utilization of health services, and mental health status of both mothers and their infants.
Eligibility Criteria
Inclusion Criteria
- Women will be recruited in their third trimester of pregnancy from Yale-New Haven Hospital (YNHH) and followed for 8 months postpartum.
- Women are eligible if they are over the age of 18, in their third trimester of pregnancy, will deliver a baby at YNHH and receive prenatal care at the Women's Center.
- Meet criteria for minor or major depressive disorder.
Exclusion Criteria
- Mothers are not eligible to participate if they have previously given birth
- Are placing the baby for adoption
- Are planning to move in the next 18 months
- Are actively suicidal, psychotic or unable to provide informed consent
Data sourced from ClinicalTrials.gov (NCT01816945). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.